AOP-1 interacts with cardiac-specific protein kinase TNNI3K and down-regulates its kinase activity

Biochemistry (Moscow)

Volumn 72, Issue 11, 2007, Pages 1199-1204

  Feng, Yan ^a   Liu, Dong Qing ^b   Wang, Zhen ^c   Liu, Zhao ^a   Cao, Hui Qing ^b   Wang, Lai Yuan ^b   Shi, Na ^b   Meng, Xian Min ^b  

^a TONGJI UNIVERSITY   (China)

^b PEKING UNION MEDICAL COLLEGE   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

AOP 1; Protein kinase; Protein protein interaction; TNNI3K; Yeast two hybrid system

Indexed keywords

BIOASSAY; CARDIOLOGY; DNA; GENE ENCODING; GENE EXPRESSION; YEAST;

CONFOCAL IMMUNOFLUORESCENCE; INTERACTING KINASES;

ENZYME ACTIVITY;

ANTIOXIDANT; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; PEROXIREDOXIN; PRDX3 PROTEIN, HUMAN; PRIMER DNA; RECOMBINANT PROTEIN; TNNI3K PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ARTICLE; CELL LINE; CHEMISTRY; DOWN REGULATION; DRUG ANTAGONISM; ENZYMOLOGY; GENETIC TRANSFECTION; GENETICS; HEART MUSCLE; HUMAN; IN VITRO STUDY; METABOLISM; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN DOMAIN; TWO HYBRID SYSTEM;

ANTIOXIDANTS; BASE SEQUENCE; CELL LINE; DNA PRIMERS; DOWN-REGULATION; HUMANS; MAP KINASE KINASE KINASES; MYOCARDIUM; PEROXIREDOXINS; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN INTERACTION MAPPING; RECOMBINANT PROTEINS; TRANSFECTION; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 36448937132     PISSN: 00062979     EISSN: 16083040     Source Type: Journal    
DOI: 10.1134/S0006297907110053     Document Type: Article

References (15)

1. Manning, G., Whyte, D. B., Martinez, R., Hunter, T., and Sudarsanam, S. (2002) Science, 298, 1912-1934.
2. Zhao, Y., Meng, X. M., Wei, Y. J., Zhao, X. W., Liu, D. Q., Cao, H. Q., Liew, C. C., and Ding, J. F. (2003) J. Mol. Med., 81, 297-304.
3. Shih, S. F., Wu, Y. H., Hung, C. H., Yang, H. Y., and Lin, J. Y. (2001) J. Biol. Chem., 276, 21870-21877.
4. Feng, Y., Cao, H. Q., Liu, Z., Ding, J. F., and Meng, X. M. (2007) Gen. Physiol. Biophys., 26, 104-109.
5. Wood, Z. A., Schroder, E., Robin, Harris, J., and Poole, L. B. (2003) Trends Biochem. Sci., 28, 32-40.
6. Fujii, J., and Ikeda, Y. (2002) Redox. Rep., 7, 123-130.
7. Masaki, M., Ikeda, A., Shiraki, E., Oka, S., and Kawasaki, T. (2003) Eur. J. Biochem., 270, 76-83.
8. Tsuji, K., Copeland, N. G., Jenkins, N. A., and Obinata, M. (1995) Biochem. J., 307, 377-381.
9. Jaschke, A., Mi, H., and Tropschug, M. (1998) J. Mol. Biol., 277, 763-769.
10. Wonsey, D. R., Zeller, K. I., and Dang, C. V. (2002) Proc. Natl. Acad. Sci. USA, 99, 6649-6654.
11. Araki, M., Nanri, H., Ejima, K., Murasato, Y., Fujiwara, T., Nakashima, Y., and Ikeda, M. (1999) J. Biol. Chem., 274, 2271-2278.
12. Nemoto, Y., Yamamoto, T., Takada, S., Matsui, Y., and Obinata, M. (1990) Gene, 91, 261-265.
13. Choi, J. H., Kim, T. N., Kim, S., Baek, S. H., Kim, J. H., Lee, S. R., and Kim, J. R. (2002) Anticancer Res., 22, 3331-3335.
14. Noh, D. Y., Ahn, S. J., Lee, R. A., Kim, S. W., Park, I. A., and Chae, H. Z. (2001) Anticancer Res., 21, 2085-2090.
15. Karihtala, P., Mantyniemi, A., Kang, S. W., Kinnula, V. L., and Soini, Y. (2003) Clin. Cancer Res., 9, 3418-3424.